Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.39 USD | +10.83% | +129.23% | +210.74% |
11/04 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
11/04 | Top Midday Gainers | MT |
Chart calendar Eliem Therapeutics, Inc.
Past events on Eliem Therapeutics, Inc.
11/04/2024 06:00 pm | Acquisition of Tenet Medicines Inc by Eliem Therapeutics Inc Call |
13/09/2023 | International Kv7 Channels Symposium |
31/05/2023 | Epilepsy Therapies & Diagnostics Development Conference |
18/05/2023 | Annual General Meeting |
12/05/2023 01:40 am | Q1 2023 Earnings Release |
27/03/2023 | RSC BMCS SCI Symposium |
07/03/2023 02:40 am | Q4 2022 Earnings Release |
01/12/2022 10:10 pm | Evercore ISI HealthCONx Conference |
17/11/2022 12:20 am | Stifel Healthcare Conference |
15/11/2022 08:40 pm | Guggenheim Immunology and Neurology Conference |
14/11/2022 04:40 pm | Q3 2022 Earnings Release |
15/08/2022 03:40 pm | Interim 2022 Earnings Release |
21/07/2022 08:00 pm | Investor Meeting |
19/05/2022 10:30 pm | Annual General Meeting |
16/05/2022 03:40 pm | Q1 2022 Earnings Release |
29/03/2022 07:00 pm | Stifel CNS Day |
08/03/2022 02:40 am | FY 2021 Earnings Release |
19/02/2022 01:30 am | SVB Leerink Global Healthcare Conference |
16/02/2022 09:00 pm | Investor Meeting |
02/12/2021 01:35 am | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -35,7 -38,0 6% | -45,1 -46,3 2.43% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -47,5 -49,9 4.85% | -45,2 -48,2 6.05% |
Net income Million USD | Released Forecast Spread | -20,7 | -52,0 -57,5 9.46% | -45,2 -47,4 4.63% |
EPS USD | Released Forecast Spread | -5,25 | -4,24 -6,32 32.91% | -1,72 -1,73 0.39% |
Announcement Date | 21/06/21 | 07/03/22 | 06/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -10,7 -13,0 17.35% | -13,1 -15,2 13.32% | -13,7 -13,1 -4.59% | -8,75 -13,5 34.96% | -9,55 -8,80 -8.57% | -23,4 -7,79 -200.78% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,5 -13,0 18.57% | -13,2 -15,2 12.84% | -14,6 -13,1 -11.42% | -9,68 -13,5 28.01% | -7,76 -8,80 11.8% | -22,3 -7,79 -186.04% |
Net income Million USD | Released Forecast Spread | -10,5 -16,0 33.96% | -13,2 -14,8 10.78% | -14,6 -12,4 -18.03% | -9,68 -12,6 23.16% | -7,76 -8,65 10.27% | -22,3 -6,63 -236.28% |
EPS USD | Released Forecast Spread | 1,25 -0,63 298.41% | -0,50 -0,56 11.24% | -0,56 -0,47 -20% | -0,37 -0,43 14.45% | -0,29 -0,33 13% | -0,84 -0,25 -236% |
Announcement Date | 07/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 06/03/23 | 11/05/23 |
Past sector events for Eliem Therapeutics, Inc.
03/05/2024 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
02/05/2024 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
02/05/2024 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
02/05/2024 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
02/05/2024 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
02/05/2024 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
02/05/2024 | GERON CORPORATION: Q1 2024 Earnings Release |
02/05/2024 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELYM Stock
- Calendar Eliem Therapeutics, Inc.